Narayana Hrudayalaya Reports Strong Q1 FY26 Results with 15.4% Revenue Growth
Narayana Hrudayalaya announced robust Q1 FY26 results with consolidated revenue reaching ₹15,073.00 million, a 15.4% year-on-year increase. EBITDA grew by 10.7% to ₹3,607.00 million. India operations revenue rose by 7.8%, while the Cayman Islands facility saw a 48.4% surge. The company reported its highest-ever quarterly revenue, with profit margins remaining high. Strategic developments include expanding facilities and introducing new medical procedures across various hospitals. The company maintains a positive outlook, focusing on growth in the Cayman Islands and Integrated Care business.

*this image is generated using AI for illustrative purposes only.
Narayana Hrudayalaya , a leading healthcare service provider in India, has announced robust financial results for the first quarter of fiscal year 2026 (Q1 FY26), demonstrating significant growth and strategic expansion.
Financial Highlights
Narayana Hrudayalaya reported a consolidated operating revenue of ₹15,073.00 million for Q1 FY26, marking a substantial year-on-year growth of 15.4% compared to ₹13,063.00 million in Q1 FY25. The company's EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) stood at ₹3,607.00 million, reflecting a 10.7% increase from the previous year.
Key financial metrics for Q1 FY26 include:
Metric | Q1 FY26 | Q1 FY25 | YoY Change |
---|---|---|---|
Consolidated Revenue | ₹15,073.00 Mn | ₹13,063.00 Mn | 15.4% |
EBITDA | ₹3,607.00 Mn | ₹3,258.00 Mn | 10.7% |
EBITDA Margin | 23.9% | 24.9% | -100 bps |
PAT | ₹1,961.00 Mn | ₹2,006.00 Mn | -2.3% |
Operational Performance
The company's India operations showed steady growth, with revenue increasing by 7.8% year-on-year to ₹11,326.00 million. Notably, the Cayman Islands facility demonstrated exceptional performance, with revenue surging by 48.4% to ₹3,968.00 million.
Dr. Emmanuel Rupert, Managing Director and Group CEO of Narayana Hrudayalaya Limited, commented on the results: "The first quarter of the new fiscal year has started with a robust performance. We are pleased to report the highest-ever revenue on a quarterly basis with profit margins sustaining at high levels."
Strategic Developments
Narayana Hrudayalaya continues to focus on expanding its footprint and enhancing its service offerings:
The Rabindranath Tagore International Institute of Cardiac Sciences in Kolkata has operationalized a new block, relocating oncology daycare beds and dialysis areas.
MMI Narayana Hospital in Raipur successfully performed its first aortic valve preserving aortic replacement and total arch replacement surgery.
Narayana Superspeciality Hospital in Guwahati treated a 3-year-old for hepatoblastoma, a rare and aggressive liver cancer.
Narayana Multispeciality Hospital in HSR (Bangalore) successfully conducted its first Mitra clip procedure in Q1 FY26.
Future Outlook
The company remains optimistic about its growth trajectory, particularly in the Cayman Islands region and its Integrated Care business. Dr. Rupert added, "We will continue to invest in this business and are optimistic that it will be a significant driver of growth to the NH ecosystem."
Narayana Hrudayalaya's focus on strategic capital expenditure initiatives and deep technology-led transformation is expected to drive scalable healthcare expansion. The company also emphasizes ESG-driven operations as part of its long-term strategy.
As of June 30, 2025, Narayana Hrudayalaya's total borrowings less cash and bank balance and investments stood at ₹3,430.00 million, representing a net debt to equity ratio of 0.09.
With its strong financial performance and strategic initiatives, Narayana Hrudayalaya is well-positioned to continue its growth and expansion in the healthcare sector.
Historical Stock Returns for Narayana Hrudayalaya
1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
---|---|---|---|---|---|
+1.58% | -2.31% | -7.09% | +43.88% | +55.30% | +559.49% |